EMagin Financials

EMagin Stock Summary

EMagin competes with KULR Technology, Ouster, Common, LightPath Technologies, Daktronics, and OSI Systems. eMagin Corporation engages in the design, develop, manufacture, and market of organic light-emitting diode miniature displays on-silicon micro displays, virtual imaging products that utilize OLED micro displays, and related products in the United States and internationally. The company was founded in 1996 and is headquartered in Hopewell Junction, New York. Emagin Corp operates under Electronic Components classification in the United States and is traded on AMEX Exchange. It employs 101 people.

EMagin Key Financial Ratios

EMagin Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining EMagin's current stock value. Our valuation model uses many indicators to compare EMagin value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EMagin competition to find correlations between indicators driving EMagin's intrinsic value. More Info.EMagin is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EMagin's earnings, one of the primary drivers of an investment's value.

Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

If you are still planning to invest in EMagin check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EMagin's history and understand the potential risks before investing.